ES2127728T3 - Proteina superficial de kda de p. falciparum. - Google Patents

Proteina superficial de kda de p. falciparum.

Info

Publication number
ES2127728T3
ES2127728T3 ES91910355T ES91910355T ES2127728T3 ES 2127728 T3 ES2127728 T3 ES 2127728T3 ES 91910355 T ES91910355 T ES 91910355T ES 91910355 T ES91910355 T ES 91910355T ES 2127728 T3 ES2127728 T3 ES 2127728T3
Authority
ES
Spain
Prior art keywords
surface protein
kda
protein
falciparum surface
malaria
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91910355T
Other languages
English (en)
Inventor
Johannes Gerardus Schoenmakers
Rudolph Nicolaas Hendr Konings
Inge Irma Maria Domini Moelans
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Radboud University Nijmegen
Original Assignee
Radboud University Nijmegen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Radboud University Nijmegen filed Critical Radboud University Nijmegen
Application granted granted Critical
Publication of ES2127728T3 publication Critical patent/ES2127728T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/445—Plasmodium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

ESTA INVENCION SE REFIERE A UNA PROTEINA SUPERFICIAL 16 KDA CAPAZ DE INDUCIR UNA RESPUESTA INMUNE PROTECTORA CONTRA LAS INFECCIONES HUMANAS DE MALARIA PROVOCADAS POR EL PLASMODIUM FALCIPARUM Y A LA CLONACION Y EXPRESION DE UN GEN QUE CODIFICA LA PROTEINA ANTEDICHA. LA INVENCION TAMBIEN SE REFIERE A NUEVAS VACUNAS QUE CONTIENEN DICHA PROTEINA Y A SU USO PARA VACUNAR A SERES HUMANOS QUE CORRAN EL RIESGO DE CONTRAER LA MALARIA.
ES91910355T 1990-06-06 1991-06-01 Proteina superficial de kda de p. falciparum. Expired - Lifetime ES2127728T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909012580A GB9012580D0 (en) 1990-06-06 1990-06-06 Novel protein

Publications (1)

Publication Number Publication Date
ES2127728T3 true ES2127728T3 (es) 1999-05-01

Family

ID=10677137

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91910355T Expired - Lifetime ES2127728T3 (es) 1990-06-06 1991-06-01 Proteina superficial de kda de p. falciparum.

Country Status (16)

Country Link
EP (1) EP0597843B1 (es)
JP (1) JP3066385B2 (es)
KR (1) KR930700544A (es)
AT (1) ATE176671T1 (es)
AU (1) AU641779B2 (es)
CA (1) CA2084673C (es)
DE (1) DE69130895T2 (es)
DK (1) DK0597843T3 (es)
ES (1) ES2127728T3 (es)
GB (1) GB9012580D0 (es)
GR (1) GR3029665T3 (es)
IE (1) IE911924A1 (es)
NZ (1) NZ238401A (es)
PT (1) PT97876B (es)
WO (1) WO1991018922A1 (es)
ZA (1) ZA914227B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL9202026A (nl) * 1992-11-20 1994-06-16 Stichting Katholieke Univ Recombinant nuclëinezuur, daardoor gecodeerd polypeptide materiaal en daarop gebaseerd transmissie-blokkerend vaccin ter bestrijding van de malariaparasiet Plasmodium falciparum.
GB9616351D0 (en) * 1996-08-02 1996-09-11 Smithkline Beecham Biolog Vaccine composition
OA11520A (en) 1997-10-20 2004-02-09 Genzyme Transgenics Corp Novel modified MSP-1 nucleic acid sequences and methods for increasing mRNA levels and protein expression in cell systems.
EP1105487A1 (en) 1998-08-21 2001-06-13 THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by The Secretary, Department of Health and Human Services Recombinant multivalent malarial vaccine against plasmodium falciparum
GB0513421D0 (en) 2005-06-30 2005-08-03 Glaxosmithkline Biolog Sa Vaccines
EP2190470B1 (en) 2007-08-13 2017-12-13 GlaxoSmithKline Biologicals SA Vaccines
US20120244178A1 (en) * 2011-03-25 2012-09-27 Denise Doolan Plasmodium falciparum antigens

Also Published As

Publication number Publication date
CA2084673C (en) 2002-07-30
EP0597843A1 (en) 1994-05-25
KR930700544A (ko) 1993-03-15
DK0597843T3 (da) 1999-09-20
GR3029665T3 (en) 1999-06-30
EP0597843B1 (en) 1999-02-10
AU7962991A (en) 1991-12-31
IE911924A1 (en) 1991-12-18
PT97876B (pt) 1998-10-30
AU641779B2 (en) 1993-09-30
JP3066385B2 (ja) 2000-07-17
GB9012580D0 (en) 1990-07-25
WO1991018922A1 (en) 1991-12-12
ATE176671T1 (de) 1999-02-15
NZ238401A (en) 1994-01-26
DE69130895D1 (de) 1999-03-25
PT97876A (pt) 1992-04-30
DE69130895T2 (de) 1999-09-30
JPH06500990A (ja) 1994-01-27
ZA914227B (en) 1992-03-25
CA2084673A1 (en) 1991-12-07

Similar Documents

Publication Publication Date Title
ES2070866T3 (es) Vacunas recombinantes contra la coccidiosis.
ES2129461T3 (es) Proteina hibrida entre cs de plasmodium y hbsag.
BR0116052A (pt) imidazoquinolinas substituìdas por éter arìlico
NO996133L (no) Olje-i-vann-vaksinesammensetninger
NL300362I1 (nl) Vaccin omvattende olie/water-emulsie met tocoferolen squaleen
BR0011448A (pt) Imidazoquinolinas substituìdas por amida
DE3583347D1 (de) Klonieren von dna fuer protozoenantigene.
ES2100240T3 (es) Bacteriofagos modificados mediante ingenieria genetica y vacunas que los contienen.
NL300186I1 (nl) Acellulair vaccin.
ES2040727T3 (es) Un proceso para preparar una formulacion en aerosol en solucion de un analogo.
ES2127728T3 (es) Proteina superficial de kda de p. falciparum.
AR023535A1 (es) Nuevas composiciones.
ES2099164T3 (es) Vacuna de glicoproteina de ehv-4.
MY105313A (en) Malaria vaccine.
DE59204742D1 (de) Adhäsivkomponente zur Restaurierung der Zahnhartsubstanz
DE69127975D1 (de) Impfstoffe
SE9702242D0 (sv) Vaccine compositions V
ES2091159A1 (es) Antigeno recombinante, rsm14, procedente de schistosoma mansoni, su obtencion y utilizacion.
ES2085947T3 (es) Proteinas hibridas protectoras de plasmodium falciparum que contienen secuencias parciales de los antigenos de malaria hrpii y serp.
DK0633723T3 (da) Anvendelse af iodbrintesyre som et afrodisiakum
MX9401384A (es) Uso de vacunas anti-helminticas en el control de la enfermedad por parasitos asociada con la perdidade la inmunidad natural.
ES2054599T3 (es) Utilizacion cosmetica de dl-valina, sus esteres y/o sales para combatir la caspa.
AR245782A1 (es) Procedimiento para preparar gbp 130 h
ES1019553Y (es) Recipiente para el mojado de las cuticulas y la piel de los extremos de los dedos.
ECSP951497A (es) Proteina mayor de leishmanias acido nucleico codante para esta proteina y sus aplicaciones

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 597843

Country of ref document: ES